$ICPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IMCOR PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IMCOR PHARMACEUTICAL CO. Get notifications about new insider transactions in IMCOR PHARMACEUTICAL CO for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2005 | ICPH | IMCOR PHARMACEUTIC ... | FLEMING JONATHAN | Director | Grant | A | 0.35 | 50,286 | 17,600 | 45,011,788 | 45 M to 45 M (+0.11 %) |
Mar 22 2005 | ICPH | IMCOR PHARMACEUTIC ... | DEPTULA-HICKS DARLENE M | Director | Option Exercise | A | 2.80 | 3,000 | 8,400 | 3,000 | |
Mar 08 2005 | ICPH | IMCOR PHARMACEUTIC ... | WATSON ALAN | Director | Option Exercise | A | 36.20 | 500 | 18,100 | 4,500 | |
Mar 08 2005 | ICPH | IMCOR PHARMACEUTIC ... | GALLAGHER BRIAN M | Director | Option Exercise | A | 8.00 | 95,000 | 760,000 | 100,000 | |
Mar 08 2005 | ICPH | IMCOR PHARMACEUTIC ... | WILLIAMS TAFFY J | CEO and President | Option Exercise | A | 8.00 | 201,421 | 1,611,368 | 368,094 | |
Feb 17 2005 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Grant | A | 0.35 | 49,786 | 17,425 | 44,564,652 | 44.5 M to 44.6 M (+0.11 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | FLEMING JONATHAN | Director | Option Exercise | P | 1.00 | 1,466,668 | 1,466,668 | 1,466,668 | |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | FLEMING JONATHAN | Director | Sell | S | 0.75 | 8,770,415 | 6,577,811 | 0 | 8.8 M to 0 (-100.00 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | FLEMING JONATHAN | Director | Sell | S | 0.75 | 3,900,348 | 2,925,261 | 0 | 3.9 M to 0 (-100.00 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | FLEMING JONATHAN | Director | Buy | P | 0.75 | 11,693,887 | 8,770,415 | 26,309,167 | 14.6 M to 26.3 M (+80.01 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | FLEMING JONATHAN | Director | Buy | P | 0.75 | 5,200,464 | 3,900,348 | 14,615,280 | 9.4 M to 14.6 M (+55.24 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | FLEMING JONATHAN | Director | Buy | P | 0.75 | 2,933,334 | 2,200,001 | 9,414,816 | 6.5 M to 9.4 M (+45.26 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 1.00 | 1,452,098 | 1,452,098 | 1,452,098 | |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Sell | S | 0.75 | 8,696,548 | 6,522,411 | 0 | 8.7 M to 0 (-100.00 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Sell | S | 0.75 | 3,861,602 | 2,896,202 | 0 | 3.9 M to 0 (-100.00 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 0.75 | 11,595,397 | 8,696,548 | 26,065,491 | 14.5 M to 26.1 M (+80.13 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 0.75 | 5,148,802 | 3,861,602 | 14,470,094 | 9.3 M to 14.5 M (+55.24 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 0.75 | 2,904,195 | 2,178,146 | 9,321,292 | 6.4 M to 9.3 M (+45.26 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Option Exercise | P | 1.00 | 1,452,098 | 1,452,098 | 1,452,098 | |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Sell | S | 0.75 | 8,696,548 | 6,522,411 | 0 | 8.7 M to 0 (-100.00 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Sell | S | 0.75 | 3,861,602 | 2,896,202 | 0 | 3.9 M to 0 (-100.00 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 0.75 | 11,595,397 | 8,696,548 | 26,065,491 | 14.5 M to 26.1 M (+80.13 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 0.75 | 5,148,802 | 3,861,602 | 14,470,094 | 9.3 M to 14.5 M (+55.24 %) |
Jun 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | OXFORD BIOSCIENCE PARTNERS IV ... | 10% Owner | Buy | P | 0.75 | 2,904,195 | 2,178,146 | 9,321,292 | 6.4 M to 9.3 M (+45.26 %) |
Apr 21 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | P | 1.00 | 11,300 | 11,300 | 1,611,989 | |
Apr 21 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 0.92 | 11,300 | 10,367 | 2,133,728 | 2.1 M to 2.1 M (-0.53 %) |
Apr 19 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | P | 1.00 | 16,430 | 16,430 | 1,623,289 | |
Apr 19 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 0.95 | 16,430 | 15,561 | 2,145,028 | 2.2 M to 2.1 M (-0.76 %) |
Apr 15 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | P | 1.00 | 96,900 | 96,900 | 1,639,719 | |
Apr 15 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.16 | 96,900 | 112,171 | 2,161,458 | 2.3 M to 2.2 M (-4.29 %) |
Apr 15 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | P | 1.00 | 96,900 | 96,900 | 1,639,719 | |
Apr 15 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.16 | 96,900 | 112,171 | 2,161,458 | 2.3 M to 2.2 M (-4.29 %) |
Apr 13 2004 | ICPH | IMCOR PHARMACEUTIC ... | MCPHEE WILLIAM D | Director | Option Exercise | A | 2.20 | 60,000 | 132,000 | 60,000 | |
Jan 29 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | P | 1.00 | 56,325 | 56,325 | 1,736,619 | |
Jan 29 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.11 | 56,325 | 62,521 | 2,258,358 | 2.3 M to 2.3 M (-2.43 %) |
Jan 27 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | P | 1.00 | 13,375 | 13,375 | 1,792,944 | |
Jan 27 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.23 | 13,375 | 16,451 | 2,314,683 | 2.3 M to 2.3 M (-0.57 %) |
Jan 22 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | P | 1.00 | 11,300 | 11,300 | 1,806,319 | |
Jan 22 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.23 | 11,300 | 13,899 | 2,328,058 | 2.3 M to 2.3 M (-0.48 %) |
Jan 14 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | P | 1.00 | 26,400 | 26,400 | 1,817,619 | |
Jan 14 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | P | 1.00 | 82,600 | 82,600 | 1,844,019 | |
Jan 14 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.44 | 26,400 | 37,910 | 2,339,358 | 2.4 M to 2.3 M (-1.12 %) |
Jan 14 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.48 | 82,600 | 122,108 | 2,365,578 | 2.4 M to 2.4 M (-3.37 %) |
Jan 14 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | P | 1.00 | 26,248 | 26,248 | 1,926,619 | |
Jan 14 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | P | 1.00 | 82,977 | 82,977 | 1,900,371 | |
Jan 14 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Buy | P | 1.00 | 26,248 | 26,248 | 2,448,358 | 2.4 M to 2.4 M (+1.08 %) |
Jan 14 2004 | ICPH | IMCOR PHARMACEUTIC ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Buy | P | 1.00 | 82,977 | 82,977 | 2,422,110 | 2.3 M to 2.4 M (+3.55 %) |
Mar 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | LEVINE STUART P | 10% Owner | Gift | G | 0.00 | 4,000 | 0 | 475,105 | 479.1 K to 475.1 K (-0.83 %) |
Feb 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | DEAN RICHARD T | Director | Option Exercise | A | 1.30 | 60,000 | 78,000 | 60,000 | |
Feb 17 2004 | ICPH | IMCOR PHARMACEUTIC ... | WATSON ALAN | Director | Option Exercise | A | 2.20 | 60,000 | 132,000 | 80,000 |
Page: 1